Cargando…
The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease?
Osteoarthritis (OA) is the most common form of musculoskeletal disease with significant healthcare costs and unmet needs in terms of early diagnosis and treatment. Many of the drugs that have been developed to treat OA failed in phase 2 and phase 3 clinical trials or produced inconclusive and ambigu...
Autores principales: | Mobasheri, Ali, Kapoor, Mohit, Ali, Shabana Amanda, Lang, Annemarie, Madry, Henning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718223/ https://www.ncbi.nlm.nih.gov/pubmed/36474763 http://dx.doi.org/10.1016/j.ocarto.2021.100144 |
Ejemplares similares
-
DNA methylation and noncoding RNA in OA: Recent findings and methodological advances
por: Izda, Vladislav, et al.
Publicado: (2021) -
Mouse microRNA signatures in joint ageing and post-traumatic osteoarthritis
por: Castanheira, Catarina I.G.D., et al.
Publicado: (2021) -
Proteomic clustering reveals the kinetics of disease biomarkers in bovine and human models of post-traumatic osteoarthritis
por: Black, Rebecca Mae, et al.
Publicado: (2021) -
The lipid profile for the prediction of prednisolone treatment response in patients with inflammatory hand osteoarthritis: The HOPE study
por: Loef, Marieke, et al.
Publicado: (2021) -
The role of metabolomics in precision medicine of osteoarthritis: How far are we?
por: Zhai, Guangju
Publicado: (2021)